BridgeBio Oncology leadership to participate in investor healthcare conferences
BridgeBio Oncology Therapeutics, Inc. announced leadership team participation in upcoming investor healthcare conferences.
SOUTH SAN FRANCISCO, Calif., Sept.
01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) NASDAQ:BBOT, a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in upcoming investor confe…